학술논문
Tofacitinib to prevent anti-drug antibody formation against LMB-100 immunotoxin in patients with advanced mesothelin-expressing cancers
Document Type
Article
Author
Source
In: Frontiers in Oncology . (Frontiers in Oncology, 2024, 14)
Subject
Language
English
ISSN
2234943X